Search

everythinglearnresearchcommunity

for

Search:↓

RU58841, a substance from France, can potentially block the effects of hormones that cause hair loss and excessive hair growth, performing better than a similar substance, cyproterone acetate.

Reducing SFRP1 can promote hair growth and may help treat hair loss.

Proteasome inhibitors are promising treatments for various cancers, autoimmune diseases, and other conditions.

Targeted cancer therapies can cause skin side effects, which should be treated early to help patients' quality of life and treatment adherence.

Using 5-α-reductase inhibitors before treatment improves outcomes for patients with metastatic renal cell carcinoma.

All-trans-retinoic acid stops mink hair growth by affecting cell growth and causing cell death.

5% topical minoxidil improves hair density and quality in monilethrix patients.

5-Alpha reductase inhibitors may prevent prostate cancer but are not widely used due to concerns about trial relevance and potential risks, and more research is needed to confirm long-term benefits.

The balance between cell renewal and differentiation controls the growth of cancerous cells in mouse skin.

5-alpha reductase inhibitors help treat prostate issues in aging men, but their role in cancer prevention is debated.

Frontal fibrosing alopecia is linked to four genetic areas, especially the HLA-B*07:02 allele.

Finasteride works better for baldness in people with shorter gene repeats.

Björnstad syndrome can cause hair loss similar to androgenetic alopecia, and treatment with baricitinib and minoxidil may help.

Glioblastoma cells can make androgens, which might help the tumor grow.

Personalized sonidegib dosing can effectively treat Gorlin-Goltz syndrome with fewer side effects.

A genetic test can identify people at risk of male pattern baldness early, allowing for quicker treatment.

Genetic variations may affect how well finasteride works for BPH patients.

Tofacitinib may help treat hair loss in children with alopecia areata.

Some breast cancer treatments cause hair loss similar to male pattern baldness, which can be improved with minoxidil.

Found new possible treatments for hair loss.

JAK inhibitors are effective for long-term management of alopecia areata.

Specific mutations in a receptor cause facial abnormalities and hair loss.

Removing EGFR in skin causes inflammation and abnormal hair growth.

Brevilin-A is a safe and effective treatment for mild to moderate alopecia areata in children.

Computational tools identified 29 drugs that could potentially target 19 genes involved in chemotherapy-induced hair loss, which could lead to more effective treatments.

JAK inhibitors are safe and effective for treating moderate-to-severe alopecia areata.

A new method helps diagnose alopecia areata using specific gene markers and could guide targeted treatments.

AR-27 E-Chol siRNA can effectively regrow hair by reducing androgen receptor gene activity.

ETC-159 was safe up to 30 mg, but no tumor shrinkage was seen.